Bayer can’t dismiss Essure injuries as ‘common women’s symptoms’, class action trial told

Class Actions 2023-04-11 9:07 pm By Cindy Cameronne | Sydney

Please login to bookmark

Pharmaceutical giant Bayer cannot write off debilitating chronic pain and bleeding which patients allegedly experienced after being implanted with Essure contraceptives as “common women’s symptoms”, a court has heard in the first day of trial in a long-running class action.

Subscribe to Lawyerly to access this article.

Already a subscriber?
Lost your password?

For information on rights and reprints, contact subscriptions@lawyerly.com.au